Laddar...
Sodium glucose co-transporter 2 inhibitors for glycemic control in type 2 diabetes mellitus: Quality of reporting of randomized controlled trials
BACKGROUND: Sodium glucose co-transporter 2 inhibitors represent a novel class of antidiabetic drugs. The reporting quality of the trials evaluating the efficacy of these agents for glycemic control in type 2 diabetes mellitus has not been explored. Our aim was to assess the reporting quality of suc...
Sparad:
| I publikationen: | Perspect Clin Res |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Medknow Publications & Media Pvt Ltd
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4763513/ https://ncbi.nlm.nih.gov/pubmed/26955572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-3485.173777 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|